Drug details

Neurolite (bicisate dihydrochloride kit)

type of

Neurolite (bicisate dihydrochloride kit) single photon emission computerized tomography (SPECT) is a diagnostic radiopharmaceutical indicated as an adjunct to conventional CT or MRI imaging in the localization of stroke in patients in whom stroke has already been diagnosed.

This drug may have the following side effects:

• nausea,
• rash,
• dizziness,
• seizure,
• headache,
• agitation,
• drowsiness,
• anxiety,
• high blood pressure (hypertension),
• feeling unwell (malaise),
• hallucinations, 
• lightheadedness/fainting,
• problems with smell,
• cardiac failure,
• chest pain (angina),
• interruptions in breathing (apnea), and
• bluish discoloration of skin due to low oxygen levels (cyanosis)

The following drugs are related to Neurolite, either as a replacement or used together:

• Activase (alteplase)
• Plavix (clopidogrel bisulfate)
• Coumadin (warfarin sodium)
• HEP-LOCK U/P (preservative-free heparin lock flush solution)
• Heparin Preservative Free (heparin sodium injection preservative free)
• Heparin Sodium Injection (heparin sodium injection)